The Denosumab for Type 1 Diabetes phase 1/2 clinical trial, is a collaborative study with the Arthur Riggs Diabetes and ...

Mandana Rezaeiahari, Ph.D., assistant professor in the University of Arkansas for Medical Sciences (UAMS) Fay W. Boozman ...

The Kentucky Historical Society Foundation’s (KHSF) board of directors has named Kathey Golightly Sanders the organization’s ...

October is the month to “Ride Your Way” and fundraise for Type 1 diabetes research through the annual Ride to Defeat Diabetes ...

Breakthrough T1D was formerly known as the Juvenile Diabetes Research Foundation. The new name was announced this past June. About $99,000 has been raised toward this year’s goal of $410,000 ...

About JDRF JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its ...

Register to read this story and more for free. Signing up for an account helps us improve your browsing experience.

Type 1 diabetes was once referred to as insulin-dependent diabetes or juvenile diabetes. However, type I diabetes can present at any age. Symptoms occur when the pancreas either makes an ...

This is truly incredible.” What are the next steps in stem-cell therapy for diabetes research? Shapiro told us he was interested in continuing to work with other teams to overcome some of the ...

The Foundation announced that it had already surpassed ... Alumni and other individuals made significant contributions to scholarships, research, and programming, such as a $2 million donation ...

Last week, the World Wide Web Foundation announced in an open letter (PDF) that it would be “winding down” and “closing [its] virtual doors” after 15 years of working to make the web safer ...

Inhibiting the hormone somatostatin could one day be a new treatment option to prevent low levels of blood glucose in patients with type 1 diabetes, according to results of recent study in mice ...